Botanical species · safety record

Catha edulis

The EFSA Compendium of Botanicals holds 15 constituent measurements, 12 adverse-effect records and 3 genotoxicity assays for Catha edulis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Catha edulis (Vahl) Endl.

15Constituent measurements
15Safety records
9Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • (-)-cathinone4
  • 1-phenylpropan-1,2-dione4
  • Cathine4
  • Norephedrine2
  • Oxazolidines1

Plant parts

  • Leaves16
  • Aerial part of plants11

Preparations

  • Solvent extraction27

Effect types

  • Neurotoxicity4
  • Pulmonary and cardiac2
  • Reproductive2
  • Systemic2
  • Teratogenic2

Target tissues

  • Brain4
  • Lung2
  • Urogenital: ovaries2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
(-)-cathinoneLeavesSolvent extraction≥ 6 Microgram/gramGC-MSResolve DOI
(-)-cathinoneAerial part of plantsSolvent extraction≥ 85 Microgram/gramGC-MSResolve DOI
(-)-cathinoneAerial part of plantsSolvent extraction≤ 188 Microgram/gramGC-MSResolve DOI
(-)-cathinoneLeavesSolvent extraction≤ 368 Microgram/gramGC-MSResolve DOI
1-phenylpropan-1,2-dioneAerial part of plantsSolvent extraction≥ 6 Microgram/gramGC-MSResolve DOI
1-phenylpropan-1,2-dioneAerial part of plantsSolvent extraction≤ 52 Microgram/gramGC-MSResolve DOI
1-phenylpropan-1,2-dioneLeavesSolvent extraction≤ 114 Microgram/gramGC-MSResolve DOI
1-phenylpropan-1,2-dioneLeavesSolvent extraction≥ 3 Microgram/gramGC-MSResolve DOI
CathineLeavesSolvent extraction≤ 500 Microgram/gramGC-MSResolve DOI
CathineLeavesSolvent extraction≥ 43 Microgram/gramGC-MSResolve DOI
CathineAerial part of plantsSolvent extraction≤ 778 Microgram/gramGC-MSResolve DOI
CathineAerial part of plantsSolvent extraction≥ 255 Microgram/gramGC-MSResolve DOI
NorephedrineAerial part of plantsSolvent extraction≤ 299 Microgram/gramGC-MSResolve DOI
NorephedrineAerial part of plantsSolvent extraction≥ 17 Microgram/gramGC-MSResolve DOI
OxazolidinesAerial part of plantsSolvent extractionGC-MSResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUrogenital: ovariesLeavesSolvent extractionRat (as animal)Reproduction toxicityResolve DOI
ReproductiveUrogenital: ovariesLeavesSolvent extractionRat (as animal)Reproduction toxicityResolve DOI
TeratogenicAerial part of plantsSolvent extractionRat (as animal)Reproduction toxicityResolve DOI
TeratogenicAerial part of plantsSolvent extractionRat (as animal)Reproduction toxicityResolve DOI
NeurotoxicityBrainLeavesSolvent extractionHouse mouse (as animal)Short-term toxicityNo resolvable identifier
NeurotoxicityBrainLeavesSolvent extractionHouse mouse (as animal)Short-term toxicityNo resolvable identifier
NeurotoxicityBrainLeavesSolvent extractionHouse mouse (as animal)Short-term toxicityNo resolvable identifier
NeurotoxicityBrainLeavesSolvent extractionHouse mouse (as animal)Short-term toxicityNo resolvable identifier
Pulmonary and cardiacLungLeavesSolvent extractionHouse mouse (as animal)Chronic/long term toxicityNo resolvable identifier
Pulmonary and cardiacLungLeavesSolvent extractionHouse mouse (as animal)Chronic/long term toxicityNo resolvable identifier
SystemicLeavesSolvent extractionHouse mouse (as animal)Chronic/long term toxicityNo resolvable identifier
SystemicLeavesSolvent extractionHouse mouse (as animal)Chronic/long term toxicityNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
PositiveDNA damage and/or repairmicronucleus assayHuman (as organism)Not applicableResolve DOI
PositiveDNA damage and/or repairmicronucleus assayHuman (as organism)Not applicableResolve DOI
Positivechromosome aberrationchromosome aberration assayRat (as animal)No dataResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Krizevski, Raz., Dudai, Nativ., Bar, Einat., Lewinsohn, Efraim. Developmental patterns of phenylpropylamino alkaloids accumulation in khat (Catha edulis, Forsk.) . Journal of ethnopharmacology, 2007, vol. 114, no. 3, p. 432-438. DOI
  2. Krizevski, Raz., Dudai, Nativ., Bar, Einat., Dessow, Ilana., Ravid, Uzi., Lewinsohn, Efraim. Quantitative stereoisomeric determination of phenylpropylamino alkaloids in khat (Catha edulis Forsk.) using chiral GC-MS . Israel journal of plant sciences, 2008, vol. 56, no. 3, p. 207-213. DOI
  3. Tariq, M., Parmar, N.S., Islamr, M.W., Ai-Meshal, I.A. Evaluation of khat (Catha edulis Forssk) for antifertility activity in rats. Phytotherapy research, 1987, vol. 1, no. 4, p. 158-160. DOI
  4. al-Meshal, I A., Qureshi, S., Ageel, A M., Tariq, M. The toxicity of Catha edulis (khat) in mice.. Journal of substance abuse, 1991, vol. 3, no. 1, p. 107-15.
  5. Al-Zubairi, Adel., Ismail, Patimah., Pei, Chong Pei., Rahmat, Asmah. Genotoxic effect of Catha edulis (khat) crude extract after sub-chronic administration in rats . Environmental toxicology and pharmacology, 2008, vol. 25, no. 3, p. 298-303. DOI
  6. Ali, Elham H. A., Hegazy, Hoda G., Mosaad, Rehab M. Interaction between pro-inflammatory cytokines and brain oxidative stress biomarkers of khat, cathinone and pseudoephedrine hydrochloride intoxication in male mice. African journal of pharmacy and pharmacology, 2015, vol. 9, no. 23, p. 585-594.
  7. ISLAM, MW., ALSHABANAH, OA., ALHARBI, MM., ALGHARABLY, NMA. EVALUATION OF TERATOGENIC POTENTIAL OF KHAT (CATHA-EDULIS FORSK) IN RATS. Drug and chemical toxicology, 1994, vol. 17, no. 1, p. 51-68. DOI
  8. Kassie, F., Darroudi, F., Kundi, M., Schulte-Hermann, R., Knasmuller, S. Khat (Catha edulis) consumption causes genotoxic effects in humans. International journal of cancer, 2001, vol. 92, no. 3, p. 329-332. DOI
  9. Krizevski, Raz., Bar, Einat., Dudai, Nativ., Levy, Asaf., Lewinsohn, Efraim., Sitrit, Yaron., Ben-Shabat, Shimon. Naturally Occurring Norephedrine Oxazolidine Derivatives in Khat (Catha edulis) . Planta medica, 2012, vol. 78, no. 8, p. 838-842. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue